Psychedelic Therapy for Chronic Pain

Chronic pain conditions — including fibromyalgia, neuropathic pain, cluster headaches, and phantom limb pain — are being studied with psychedelics as non-opioid alternatives. Ketamine infusion therapy is already widely used off-label for chronic pain conditions. Psilocybin and LSD show analgesic properties, and anecdotal evidence from cluster headache patients has driven formal research interest.

50Clinical Trials

0Recruiting Now

0Companies

The psychedelic approach to pain differs fundamentally from opioids: rather than blocking pain signals, these substances may alter the psychological and emotional relationship to pain, reducing suffering even when the sensory signal remains. This is particularly relevant for conditions where the pain has become self-reinforcing and treatment-resistant.

Evidence & Proven Benefits

What clinical research has shown for Chronic Pain, with citations to the studies behind each finding

Phase 2

Controlled research on psilocybin for cluster headache is still exploratory

A small randomized, double-blind, placebo-controlled trial tested a low-dose psilocybin pulse regimen for cluster headache. The formal efficacy outcomes were not statistically significant given the small sample, though observed signals have prompted calls for larger trials. This is a promising but unproven area.

Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trialSchindler et al. — Headache: The Journal of Head and Face Pain, 2022

These summaries are for general education, not medical advice. Most psychedelic therapies remain investigational and are not yet approved — always consult a qualified clinician.